The structures of the bacterial RNA polymerase holoenzyme have provided detailed information about the intersubunit interactions within the holoenzyme. Functional analysis indicates that one of these is critical in enabling the holoenzyme to recognize the major class of bacterial promoters. It has been suggested that this interaction, involving the flap domain of the β subunit and conserved region 4 of the σ subunit, is a potential target for regulation. Here we provide genetic and biochemical evidence that the σ region 4/β-flap interaction is targeted by the transcription factor AsiA. Specifically, we show that AsiA competes directly with the β-flap for binding to σ region 4, thereby inhibiting transcription initiation by disrupting the σ region 4/β-flap interaction.
The structures of the bacterial RNA polymerase holoenzyme have provided detailed information about the intersubunit interactions within the holoenzyme. Functional analysis indicates that one of these is critical in enabling the holoenzyme to recognize the major class of bacterial promoters. It has been suggested that this interaction, involving the flap domain of the ␤ subunit and conserved region 4 of the subunit, is a potential target for regulation. Here we provide genetic and biochemical evidence that the region 4͞␤-flap interaction is targeted by the transcription factor AsiA. Specifically, we show that AsiA competes directly with the ␤-flap for binding to region 4, thereby inhibiting transcription initiation by disrupting the region 4͞␤-flap interaction.
T he bacterial RNA polymerase (RNAP) holoenzyme consists of a catalytically proficient core enzyme (subunit structure ␣ 2 ␤␤Ј) and a subunit that confers on the holoenzyme the ability to recognize specific promoter sequences (1) . The primary factor in Escherichia coli is 70 , and the 70 -containing holoenzyme (E 70 ) typically recognizes promoters defined by two conserved sequence elements (the Ϫ10 and Ϫ35 hexamers) positioned roughly 10 and 35 bp upstream of the transcription start point (1) . Most factors share four conserved regions (2) , and of these, regions 2 and 4 interact with the Ϫ10 and Ϫ35 elements, respectively (1) . Nevertheless, intact 70 recognizes specific promoter sequences only in the context of the holoenzyme because of critical conformational changes in 70 that take place when it associates with the core enzyme (3) . These include an increase in the interdomain distance between regions 2 and 4 that is caused by an interaction between region 4 and the ␤-flap domain (4) . The region 4͞␤-flap interaction is essential for the recognition of Ϫ10͞Ϫ35 promoters because it positions regions 2 and 4 of 70 for simultaneous interaction with the promoter Ϫ10 and Ϫ35 elements (4) . This role of the region 4͞␤-flap interaction suggested that there may exist regulatory factors that inhibit transcription from Ϫ10͞Ϫ35 promoters by disrupting the region 4͞␤-flap interaction (4, 5) .
Here we examine the mechanism of action of the bacteriophage T4-encoded antifactor AsiA. AsiA is known to bind tightly to region 4 of 70 and inhibit transcription from Ϫ10͞Ϫ35 promoters when complexed with the holoenzyme (6) (7) (8) (9) (10) . The finding that AsiA binds to region 4 of 70 and inhibits transcription specifically from Ϫ10͞Ϫ35 promoters raises the possibility that AsiA works by disrupting the 70 region 4͞␤-flap interaction, a model that is consistent with recent NMR analysis (11) . We provide genetic evidence that AsiA and the ␤-flap interact with overlapping determinants on 70 region 4. We then present complementary biochemical and biophysical evidence that AsiA works by a competitive binding mechanism, inhibiting transcription from Ϫ10͞Ϫ35 promoters by disrupting the region 4͞␤-flap interaction in the context of the holoenzyme.
Materials and Methods
Mutant Screen. Mutagenic PCR was used to introduce random mutations into the appropriate fragment of plasmid pBR␣-70 D581G as described (12) . A pool of mutant ␣-70 D581G chimeras was transformed into strain FЈ93ϩ62 (13) bearing the test promoter (plac2op) and a linked lacZ reporter gene on an FЈ episome and containing pAC⌬Ϫ35cI-AsiA K20A (a derivative of pAC⌬Ϫ35cI-AsiA; ref. 13 ). The resulting transformants were plated on indicator medium containing 5-bromo-4chloro-3-indolyl ␤-D-galactoside (X-Gal) (40 g͞ml) and the ␤-galactosidase inhibitor tPEG (250 M), permitting the identification of colonies containing ␣-70 D581G mutants that caused a reduction in cI-AsiA-stimulated transcription from the test promoter. Plasmid DNA from these colonies was isolated, and the mutant ␣-70 D581G chimeras were assayed for their abilities to stimulate transcription from placConsϪ35C.1 (identical in sequence to placConsϪ35C from the transcription start point to position Ϫ62; see ref. 12 ) in strain BG18. Mutants were sought that stimulated transcription from placConsϪ35C.1 as well or nearly as well as the parent chimera.
␤-Galactosidase Assays. Cells were grown in LB supplemented with the appropriate antibiotics at the following concentrations: carbenicillin (100 g͞ml), chloramphenicol (25 g͞ml), and kanamycin (50 g͞ml). Isopropyl-␤-D-thiogalactoside (IPTG) was provided at the indicated concentrations. SDS⅐CHCl 3permeabilized cells were assayed as described (13) . Assays were performed at least three times in duplicate on separate occasions, with similar results. Values are the averages from one experiment; duplicate measurements differed by Ͻ5%.
Proteins. N-terminally his-tagged versions of wild-type 70 and the 70 mutants were purified as described after overproduction from the corresponding derivative of vector pLHN12-His (14) . E. coli RNAP core enzyme was purchased from Epicentre, and holoenzymes were assembled by incubation of RNAP core (62.5 nM) with a 5-fold molar excess of the appropriate 70 at 37°C for 10 min. C-terminally his-tagged AsiA was purified as described (15) and AsiA-containing RNAP holoenzymes were assembled by preincubating the appropriate 70 (in 5-fold molar excess over RNAP core) with different concentrations of AsiA in storage buffer (14) at 4°C for 10 min. RNAP core (62.5 nM) was then added, and the mixtures were incubated at 37°C for 10 min.
In Vitro Transcription Assays. Assays were performed by preincubating template DNA (10 nM) in transcription buffer (10 mM MgCl 2 ͞90 mM KCl͞40 mM Tris⅐HCl, pH 8.0͞125 g/ml BSA͞5 mM DTT͞10% vol/vol glycerol). RNAP holoenzyme (with or without AsiA) was then added to a final concentration of 10 nM and the reactions incubated for 10 min at 37°C to allow open complex formation. Transcription was initiated by addition of 200 M GTP (initiating nucleotide), 5 M ATP, 5 M CTP, 3 M [␣-32 P]UTP at 2 mCi͞ml, and 100 g͞ml heparin (1 Ci ϭ 37 GBq). The total volume of each reaction was 25 l. Reactions were incubated for 15 min at 37°C and quenched by the addition of 25 l of stop solution (95% vol/vol formamide͞20 mM EDTA͞0.05% wt/vol bromophenol blue͞0.05% wt/vol xylene cyanol). Samples were electrophoresed on 6% (wt͞vol) polyacrylamide sequencing gels. Bands were visualized by Phospho-rImager, and the data were analyzed by IMAGEQUANT.
Fluorescence Resonance Energy Transfer (FRET) Analysis. AsiA͞RNAP holoenzyme complexes. 70 labeled at residue 581 by cpm (Molecular Probes) was prepared by using mutant 70 containing a single reactive cysteine at position 581 as described (3) . AsiA labeled at position 86 with fluorescein (Molecular Probes) was prepared by using mutant AsiA containing a single reactive cysteine at position 86 as described (15) . To assess the binding of AsiA to RNAP holoenzyme containing wild-type or mutant 70 , equal amounts of labeled AsiA͞holoenzyme complex and unlabeled holoenzyme were mixed together as follows. Core (12.5 pM) was combined with 11 pM 70 -cpm and 10 pM AsiA-FAM (fluorescein malemide) in 200 l of buffer F containing 50 mM Tris⅐HCl (pH 8), 100 mM NaCl, and 0.5 mg͞ml BSA in a quartz cuvette. The mixture was incubated for 20Ј at 37°C to ensure that labeled holoenzyme-AsiA complex reached equilibrium. Under these conditions, at least 90% of labeled 70 is bound to the core (data not shown; see also ref. 4). Then, 5 l containing 12.5 pM core and 11 pM unlabeled wild-type or mutant 70 were added to the labeled holoenzyme-AsiA complex. The mixture was incubated at 37°C for 5 min before measurements were taken. Fluorescence emission spectra with the excitation at 380 nm (cpm excitation) were recorded from 400 to 600 nm. Fluorescence spectra were recorded by using an Aminco Bowman Series 2 spectrofluorometer (Spectronic Instruments, Rochester, NY). Spectra were acquired with the scan rate of 2 nm͞sec and with excitation and emission slits of 2 and 4 nm, correspondingly. The ratio of fluorescence intensity In strain FЈ93ϩ62 this test promoter is linked to lacZ on an FЈ episome. Replacement of the RNAP ␣-CTD by a fragment of that harbors region 4 permits interaction with the AsiA moiety of either of two DNA-bound cI-AsiA fusion proteins. The graph shows the effect of the cI-AsiA fusion protein (with or without the K20A substitution) on transcription in vivo from plac2op in the presence of the ␣-70 chimera (cI-AsiA and cI-AsiA K20A) or the ␣-70 D581G chimera (cI-AsiA K20A only). FЈ93ϩ62 cells harboring compatible plasmids directing the synthesis of the indicated proteins were grown in the presence of 50 M IPTG and assayed for ␤-galactosidase activity. Plasmids pAC⌬Ϫ35cI-AsiA (13) and derivative pAC⌬Ϫ35cI-AsiA K20A directed the synthesis of the cI-AsiA and cI-AsiA K20A fusion proteins, and plasmids pBR␣-70 (28) , pBR␣ (28) , and pBR␣-70 D581G (12) directed the synthesis of the ␣-70 chimera, full-length ␣, and the ␣-70 D581G chimera. (B) Effect of F563Y substitution in moiety of ␣-70 D581G chimera on transcription in vivo from plac2op in presence of the cI-AsiA K20A fusion protein. FЈ93ϩ62 cells harboring compatible plasmids directing the synthesis of the indicated proteins were grown in the presence of 50 M IPTG and assayed for ␤-galactosidase activity. Plasmid pAC⌬Ϫ35cI-AsiA K20A directed the synthesis of the cI-AsiA K20A fusion protein and plasmids pBR␣-70 D581G, pBR␣-70 D581G͞F563Y, and pBR␣ directed the synthesis of the ␣-70 D581G chimera, the ␣-70 D581G͞F563Y chimera, and full-length ␣. (C) Substitution F563Y in moiety of ␣-70 D581G chimera does not affect the ability of the tethered 70 region 4 moiety to bind DNA. The diagram depicts test promoter placConsϪ35C.1 (see Materials and Methods), which contains a consensus Ϫ35 element centered 55 bp upstream from the transcription start site. In strain BG18, this test promoter is linked to lacZ on an FЈ episome. Replacement of the RNAP ␣-CTD by a fragment of that harbors region 4 containing the D581G substitution permits interaction with the Ϫ35 element centered at position Ϫ55. The graph shows the effect of the F563Y substitution in the moiety of the ␣-70 D581G chimera on transcription in vivo from placConsϪ35C.1. BG18 cells harboring compatible plasmids directing the synthesis of the indicated proteins were grown in the presence of 50 M IPTG and assayed for ␤-galactosidase activity. Plasmids pBR␣-70 D581G, pBR␣-70 D581G͞F563Y, and pBR␣ directed the synthesis of the ␣-70 D581G chimera, the ␣-70 D581G͞F563Y chimera, and full-length ␣. (D) E 70 F563Y is resistant to inhibitory effect of AsiA on transcription from a Ϫ10͞Ϫ35 promoter. Shown are results of single round in vitro transcription assays performed on Ϫ10͞Ϫ35 promoter T7A2 in the absence or presence of increasing concentrations of AsiA (50 or 100 nM) by using wild-type E 70 or mutant E 70 bearing the F563Y substitution in 70 .
integrated between 500 and 600 nm (acceptor emission) to the intensity integrated between 400 and 500 nm (donor emission) was used as an apparent parameter describing the extent of FRET between the donor and acceptor. The value of this parameter is directly proportional to the amount of E 70 -cpm-AsiA-FAM complex in solution. For these experiments, wildtype RNAP core enzyme was prepared by in vitro reconstitution as described (16) , and unlabeled wild-type and mutant 70 subunits were purified as described (14) . AsiA͞ 70 complexes. Complexes between labeled 70 and labeled AsiA were formed by mixing the proteins in 200 l of buffer F in a quartz cuvette at a ratio of 1:1.5 (50 nM 70 -cpm and 75 nM AsiA-FAM). Relative binding affinities of 70 mutants were assessed by adding various amounts of unlabeled protein to the mixture of labeled 70 and AsiA. Addition of unlabeled 70 (wild type or mutant) led to a substitution of labeled 70 in the 70 -cpm-AsiA-FAM complex by the unlabeled competitor protein, resulting in diminished intensity of the FRET signal.
Results
Design of Genetic Screen. To probe the mechanism of transcription inhibition by AsiA, we took a genetic approach. Previous work suggested that the interaction of AsiA with 70 region 4 is required for AsiA-mediated transcription inhibition (8) (9) (10) . Therefore, we sought to identify amino acid residues in region 4 of 70 that participate directly in the interaction with AsiA through the use of a bacterial two-hybrid assay (17, 18) . In this assay, contact between a protein domain fused to a component of RNAP and an interacting protein (or protein domain) fused to a DNA-bound protein (here, the cI protein of bacteriophage ) activates transcription of a lacZ reporter gene (see Fig. 1A ).
In particular, we made use of a cI-AsiA fusion protein and an ␣-70 chimera in which the C-terminal domain of ␣ (the ␣-CTD) has been replaced by a fragment of 70 (residues 528-613) encompassing region 4 ( Fig. 1 A) . The cI-AsiA fusion protein activated transcription from test promoter plac2op Ϸ3-fold specifically in cells containing the ␣-70 chimera ( Fig. 1 A; see also ref. 13 ).
To increase the sensitivity of our genetic screen, we sought to identify a cI-AsiA variant that would activate transcription more strongly in our two-hybrid assay. Because AsiA forms stable homodimers that must first dissociate for AsiA to bind to 70 region 4 (11, 19, 20) , we hypothesized that the ability of the fused AsiA moiety to activate transcription might be limited by its tendency to dimerize in the context of the dimeric cI-AsiA fusion protein (13) . To test this hypothesis, we introduced into the AsiA moiety an amino acid substitution (K20A) that specifically disrupts the formation of AsiA homodimers without inhibiting the ability of AsiA to interact with 70 region 4 (R.J.B.U. and J.U., unpublished data). The resulting cI-AsiA K20A variant stimulated transcription from promoter plac2op Ϸ36-fold in the presence of the ␣-70 chimera ( Fig. 1 A) , providing strong support for the hypothesis that the interaction of the fused AsiA moieties of the cI-AsiA dimer competes with the interaction of the AsiA and 70 region 4 moieties in the two-hybrid assay.
To identify amino acid substitutions in 70 region 4 that specifically affected its interaction with AsiA and eliminate from consideration those that disrupted the structural integrity of the 70 moiety, we took advantage of a related genetic assay that reports on the ability of the tethered 70 region 4 moiety to bind to a Ϫ35 element (12) . In this assay, the interaction of the region 4 moiety with an ectopic Ϫ35 element positioned upstream of the core promoter elements activates transcription from the test promoter depicted in Fig. 1C (promoter placCons-35C.1) . We showed previously that although the wild-type 70 moiety does not bind detectably to the ectopic Ϫ35 element of placConsϪ35C, a variant bearing amino acid substitution D581G does (12) . Thus, we used the D581G variant of the ␣-70 chimera in our genetic screen, having first verified that the D581G substitution did not compromise the ability of the AsiA moiety of the cI-AsiA fusion protein to interact with 70 region 4 in our two-hybrid assay ( Fig. 1 A) .
Identification and Characterization of a 70 Mutant That Is Specifically
Defective in the Interaction with AsiA. We introduced random mutations into the gene fragment encoding the 70 moiety of an ␣-70 D581G chimera. After screening the mutagenized library of ␣-70 D581G chimeras, we identified an amino acid substitution, F563Y, that reduced cI-AsiA K20A-stimulated transcription from test promoter plac2op, but had only a slight effect on the ability of the tethered 70 moiety to activate transcription from test promoter placCons-35C.1 ( Fig. 1 B and  C) . We conclude that substitution F563Y specifically weakens (but does not abolish) the interaction of 70 region 4 with AsiA.
We then wished to determine whether or not introduction of the F563Y substitution into full-length 70 would affect the ability of AsiA to inhibit transcription from a Ϫ10͞Ϫ35 promoter (T7A2) in vitro. Reconstituted holoenzymes E 70 and E 70 F563Y were equally proficient in initiating transcription from this promoter in the absence of AsiA (Fig. 1D ). As expected, AsiA inhibited transcription by the wild-type holoenzyme (Fig. 1D, lanes 1-3) . In contrast, the mutant holoenzyme containing 70 F563Y was almost completely refractory to the inhibitory effect of AsiA (Fig. 1D, compare lanes 4-6 with lanes  1-3) . Thus, amino acid substitution F563Y in 70 both weakened the 70 region 4͞AsiA interaction in the two-hybrid assay and disrupted AsiA-mediated transcription inhibition in vitro, indicating that the 70 region 4͞AsiA interaction detected in the two-hybrid assay is required for AsiA to function as an inhibitor of transcription.
Substitutions of 70 Residue 563 Affect both the 70 ͞AsiA and the 70 ͞␤-Flap Interactions. Two independent lines of evidence implicate residue F563 of 70 in the interaction of 70 region 4 with the ␤-flap. First, the RNAP holoenzyme structures indicate that the residue corresponding to F563 of 70 lies at the region 4͞␤-flap interface (21, 22) . Second, we found that a substitution (F278L) affecting the corresponding residue of 38 (the stationary phase-specific factor in E. coli) specifically disrupted the interaction of 38 region 4 with the ␤-flap (B.E.N., unpublished data). We therefore wished to compare the effects of the F563Y and F563L substitutions in 70 on both the 70 region 4͞␤-flap and the 70 region 4͞AsiA interactions. Accordingly, we introduced the F563L substitution into the 70 moiety of the ␣-70 D581G chimera. Whereas the F563L substitution in 70 region 4 nearly abolished the stimulatory effect of the cI-␤-flap fusion protein from test promoter plac2op ( Fig. 2A) , it had no effect on the ability of the cI-AsiA K20A fusion protein to stimulate transcription from the same promoter (Fig. 2B) . Conversely, we found that amino acid substitution F563Y in 70 region 4, which reduced the stimulatory effect of the cI-AsiA K20A fusion protein, had no effect on the ability of the cI-␤-flap fusion protein to stimulate transcription ( Fig. 2 A and B) . We conclude, therefore, that the F563L substitution specifically affects the interaction of 70 region 4 with the ␤-flap, whereas the F563Y substitution specifically affects its interaction with AsiA, suggesting that the molecular details of the two interactions differ.
Evidence That AsiA Competes with the ␤-Flap for Binding to 70
Region 4. The identification of an amino acid residue (F563) that apparently participates in both the 70 region 4͞␤-flap and the 70 region 4͞AsiA interactions suggested that AsiA and the ␤-flap interact with overlapping determinants of 70 region 4. Therefore, AsiA and the ␤-flap would be expected to compete for binding to 70 region 4 in the context of the RNAP holoenzyme. This competitive binding model for AsiA-mediated transcription inhibition implies that the relative affinities of AsiA and the ␤-flap for 70 region 4 should dictate whether AsiA can effectively inhibit transcription from Ϫ10͞Ϫ35 promoters. To test this competitive binding model, we asked whether weakening the interaction of 70 F563Y with the ␤-flap could restore the susceptibility of E 70 F563Y to AsiA. To do this, we took advantage of two amino acid substitutions in 70 (R541C and L607P) that specifically disrupt the interaction between 70 region 4 and the ␤-flap (B.E.N., unpublished data). We first used the two-hybrid assay to test whether these substitutions had any effect on the interaction of 70 region 4 and AsiA. When introduced into 70 region 4 either singly or in combination, neither the R541C substitution nor the L607P substitution significantly affected the 70 region 4͞AsiA K20A interaction (data not shown).
We then introduced substitutions R541C and L607P, singly and in combination, into full-length 70 already containing the F563Y substitution. We used these mutant 70 proteins as well as 70 R541C, 70 L607P, 70 R541C͞L607P, 70 F563Y, and 70 WT to reconstitute a set of holoenzymes and examined the abilities of these holoenzymes to initiate transcription from the T7A2 promoter in the absence or presence of AsiA ( Fig. 3 ; see also Table 1 ). As in the experiment of Fig. 1D , we found that AsiA efficiently inhibited transcription by E 70 WT (Fig. 3, lanes  1-3) but was unable to inhibit transcription by E 70 F563Y (Fig.  3, lanes 4-6) . Furthermore, AsiA inhibited transcription by E 70 R541C, E 70 L607P, and E 70 R541C͞L607P even more efficiently than it inhibited transcription by E 70 WT (Fig. 3,  compare lanes 7-9, 10-12, and 13-15, with lanes 1-3) . Finally, we Fig. 3 . Mutations that weaken the 70 region 4͞␤-flap interaction restore sensitivity of E 70 F563Y to AsiA. Shown are the results of single round in vitro transcription assays performed on T7A2 promoter in the absence or presence of increasing concentrations of AsiA (50 or 100 nM) by using wild-type or mutant RNAP holoenzymes. For each RNAP, the transcripts were quantified (by IMAGEQUANT) to determine the magnitude of the inhibitory effect of AsiA. Thus, the amount of transcript produced in the absence of AsiA was set at 100% for each holoenzyme. Note that all of the mutant holoenzymes except those containing 70 with both the R541C and L607P substitutions initiated transcription from T7A2 approximately as well as E 70 WT (compare lanes 4, 7, 10, 16, and 19 with lane 1) . E 70 R541C͞L607P and E 70 F563Y͞R541C͞L607P initiated transcription from T7A2 only Ϸ50% as efficiently as E 70 WT. Disruption of the interaction of 70 with the ␤-flap is expected to cause defects in the recognition of Ϫ10͞Ϫ35 promoters, and analysis of the effects of the R541C and L607P substitutions indicated that it was necessary to introduce both of these substitutions into 70 to detect a significant defect in the recognition of strong Ϫ10͞Ϫ35 promoters in vitro (B.E.N., unpublished data). No defects in the recognition of a control extended Ϫ10 promoter were detected with 70 mutants bearing substitutions R541C and L607P either singly or in combination (B.E.N., unpublished data).
found that introduction of substitutions R541C and͞or L607P into 70 F563Y enabled AsiA to inhibit transcription by the corresponding doubly and triply substituted holoenzymes (Fig. 3 , lanes 16-18, 19-21, and 22-24) . Moreover, the efficiency with which AsiA inhibited transcription by each of these holoenzymes correlated with the severity of the ␤-flap-binding defect of the corresponding mutant 70 . That is, 70 substitutions R541C, L607P, and R541C͞L607P resulted in increasingly severe ␤-flapbinding defects (B.E.N., unpublished data), and correspondingly, E 70 F563Y͞R541C, E 70 F563Y͞L607P, and E 70 F563Y͞R541C͞L607P were increasingly susceptible to inhibition by AsiA (Fig. 3, lanes 16-24) . These findings demonstrate that the effect of weakening the 70 region 4͞AsiA interaction can be suppressed by weakening a competing interaction between 70 region 4 and the ␤-flap.
To assay directly the binding of AsiA to the wild-type and mutant holoenzymes in solution, we used a FRET-based binding assay. FRET donor and acceptor probes were incorporated into AsiA and 70 by using single-cysteine mutants of the proteins. The labeled polypeptides were mixed with RNAP core to form the AsiA-containing holoenzyme. Association of acceptorlabeled AsiA with donor-labeled holoenzyme produced a FRET signal. The labeled holoenzyme-AsiA complex was then mixed with an equal amount of unlabeled holoenzyme (containing either wild-type or mutant 70 ), and the decrease in FRET was quantified. The decrease in FRET reflects the ability of the unlabeled holoenzyme species to compete with the labeled wild-type holoenzyme for the binding of labeled AsiA. Compared to the wild-type holoenzyme, the holoenzyme containing the 70 F563Y mutant competed poorly for the binding of AsiA, as expected ( Fig. 4A ). Furthermore, this defect in the ability of the 70 F563Y-containing holoenzyme to bind AsiA was suppressed by the introduction into 70 F563Y of substitutions R541C and͞or L607P, which weaken the 70 region 4͞␤-flap interaction (Fig. 4A) . The results of the FRET analysis thus paralleled the results of the in vitro transcription assays (Fig. 3) , indicating that the ability of AsiA to inhibit transcription correlates with its ability to bind the holoenzyme.
We performed a control FRET experiment to confirm that the introduction of substitutions R541C and L607P into the 70 F563Y mutant did not affect the affinity of AsiA for free 70 . In this experiment, donor͞acceptor complexes were formed with labeled AsiA and labeled 70 . Increasing concentrations of unlabeled wild-type or mutant 70 were then added, and the decrease in FRET was quantified. The decrease in FRET signal reflects the ability of each added 70 to compete with the labeled 70 for the binding of labeled AsiA (Fig. 4B) . The results confirmed that the binding of AsiA to free 70 was weakened significantly by the F563Y substitution and that this binding defect was not reversed by either the R541C or the L607P substitution (or the combination of the two) ( Fig. 4B ).
Discussion
Our findings provide strong support for the idea that AsiA targets the 70 ͞␤-flap interaction, inhibiting transcription from Ϫ10͞Ϫ35 promoters by displacing 70 region 4 from the ␤-flap in the context of the holoenzyme. We note that this competitive binding model for AsiA-mediated transcription inhibition may provide an explanation for the previous demonstration that AsiA binds more readily to free 70 than to the 70 -containing holoenzyme (23) . Our data are consistent with the results of a recent analysis of the 70 region 4͞AsiA interaction by NMR (11) . This analysis identified amino acid side chains in 70 region 4 that are contacted by AsiA in the complex that forms when AsiA is combined with a pair of 70 peptides comprising subregions 4.1 and 4.2. The identified side chains (which include F563) are distinct from those that participate in contacts with the 
Ն ϩ ϩ ϩ ϩ *Boldface indicates that the F563Y substitution disrupts the interaction of 70 region 4 with AsiA (but not with the ␤-flap). † Italics indicate that the designated substitutions disrupt the interaction of 70 region 4 with the ␤-flap (but not with AsiA).
Fig. 4. Effects of substitutions in 70 on
AsiA binding in the context of RNAP holoenzyme (A) and free 70 (B). (A) The indicated RNAP holoenzymes were added to a ternary complex containing RNAP core and fluorescently labeled 70 and AsiA. The decrease in FRET signal was determined and converted to competition efficiency (assumed to be 100% for wild-type RNAP holoenzyme). (B) A complex between fluorescently labeled 70 and AsiA was formed and the effect of the addition of increasing concentrations of unlabeled wild-type or mutant 70 subunits on the FRET signal was determined (plus signs, wild-type 70 ; circles, 70 F563Y; triangles, 70 F563Y͞R541C; diamonds, 70 F563Y͞L607P; squares, 70 F563Y͞R541C͞L607P). The decrease in FRET signal reflects the ability of each added 70 to compete for labeled AsiA.
Ϫ35 element as seen in the crystal structure of a region 4-DNAcomplex (24), but map instead to a hydrophobic pocket that binds the ␤-flap in the context of the holoenzyme (21, 22) . Additional evidence indicated that the binding of AsiA to the 70 -containing holoenzyme resulted in a decrease in the interdomain distance between regions 2 and 4 of 70 , consistent with the expected disruption of the 70 region 4͞␤-flap interaction (11) .
We found that the ability of AsiA to inhibit transcription by the 70 -containing holoenzyme depends on the relative affinities of AsiA and the ␤-flap for 70 region 4, supporting a competitive binding mechanism for AsiA-mediated transcription inhibition. Specifically, we showed that, when the interaction between 70 region 4 and AsiA is weakened by substitution F563Y in 70 , AsiA fails to inhibit transcription unless the interaction between 70 region 4 and the ␤-flap is also weakened by the introduction of one or more additional substitutions into 70 (see Table 1 ). A prediction of the competitive binding model for AsiA action is that AsiA's ability to inhibit transcription would be compromised not only by amino acid substitutions that weaken the interaction of AsiA with 70 region 4, but also by those that strengthen the interaction of 70 region 4 with the ␤-flap. We have recently identified amino acid substitutions in 70 region 4 that strengthen its interaction with the ␤-flap in the two-hybrid assay (ref. 4 and S.J.G., unpublished data). As predicted by the competitive binding model, we found that these substitutions, which did notweaken the interaction of 70 region 4 with AsiA, blocked the ability of AsiA to inhibit transcription (B.D.G., unpublished data).
In addition to its role as an inhibitor of 70 -dependent transcription from Ϫ10͞Ϫ35 promoters, AsiA functions as a coactivator of T4 middle gene transcription (25, 26) . T4 middle promoters (which are recognized by the 70 -containing holoenzyme) bear a binding site for the phage-encoded regulator MotA that is located at approximately the position of the Ϫ35 element of a standard Ϫ10͞Ϫ35 promoter (25) . Activation of these promoters depends on a protein-protein interaction between DNA-bound MotA and residues near the C terminus of 70 (27) . Because this portion of 70 has also been implicated in the ␤-flap interaction (21, 22) , we speculate that, by disrupting the 70 region 4͞␤-flap interaction, AsiA may facilitate the MotA͞ 70 region 4 interaction.
The demonstration that AsiA works by disrupting the region 4͞␤-flap interaction suggests that it will be worthwhile to search for other regulators that target this interaction in the context of the 70 -containing holoenzyme as well as other holoenzyme species. Moreover, because evidence indicates that the strength of the region 4͞␤-flap interaction varies with different factors (4), different holoenzyme species are likely to be differentially susceptible to such regulators.
